Business Description
McKesson Corp
ISIN : US58155Q1031
Total Employee Number:
43,000Compare
Compare
Traded in other countries / regions
MCK.USAM1CK34.Brazil0JZU.UKMCK.MexicoMCK.Germany1MCK.Italy IPO Date
2026-09-09Description
McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.44 | |||||
Equity-to-Asset | -0.05 | |||||
Debt-to-Equity | -2.76 | |||||
Debt-to-EBITDA | 1.56 | |||||
Interest Coverage | 24.7 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 5.85 | |||||
Beneish M-Score | -2.54 | |||||
WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 18.7 | |||||
3-Year EBITDA Growth Rate | 14.4 | |||||
3-Year EPS without NRI Growth Rate | 18.4 | |||||
3-Year FCF Growth Rate | 10.4 | |||||
3-Year Book Growth Rate | -9.9 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 13.76 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 7.22 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.89 | |||||
Quick Ratio | 0.52 | |||||
Cash Ratio | 0.07 | |||||
Days Inventory | 23.73 | |||||
Days Sales Outstanding | 24.73 | |||||
Days Payable | 55.89 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Dividend Growth Rate | 14.9 | |||||
3-Year Average Share Buyback Ratio | 4.1 | |||||
Shareholder Yield % | 5.74 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 3.64 | |||||
Operating Margin % | 1.65 | |||||
Net Margin % | 1.12 | |||||
EBITDA Margin % | 1.83 | |||||
FCF Margin % | 1.49 | |||||
ROE % | Neg. Equity | |||||
ROA % | 5.46 | |||||
ROIC % | 21.11 | |||||
3-Year ROIIC % | 21.99 | |||||
ROC (Joel Greenblatt) % | 143.86 | |||||
ROCE % | 40.83 | |||||
Years of Profitability over Past 10-Year | 9 | |||||
Moat Score | 7 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 23.59 | |||||
PE Ratio without NRI | 21.6 | |||||
Shiller PE Ratio | 66.79 | |||||
Price-to-Owner-Earnings | 18.1 | |||||
PS Ratio | 0.26 | |||||
Price-to-Free-Cash-Flow | 17.76 | |||||
Price-to-Operating-Cash-Flow | 15.91 | |||||
EV-to-EBIT | 16.67 | |||||
EV-to-Forward-EBIT | 15 | |||||
EV-to-EBITDA | 14.97 | |||||
EV-to-Forward-EBITDA | 13.58 | |||||
EV-to-Revenue | 0.27 | |||||
EV-to-Forward-Revenue | 0.25 | |||||
EV-to-FCF | 18.27 | |||||
Price-to-GF-Value | 1.06 | |||||
Price-to-Projected-FCF | 1.89 | |||||
Price-to-Median-PS-Value | 1.52 | |||||
Earnings Yield (Greenblatt) % | 6 | |||||
FCF Yield % | 5.98 | |||||
Forward Rate of Return (Yacktman) % | -18.54 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
McKesson Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 353,307.747 | ||
| EPS (TTM) (€) | 32.119 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | - | ||
| 14-Day ATR (€) | - | ||
| 20-Day SMA (€) | - | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (€) | 754.8 - 766.4 | ||
| Shares Outstanding (Mil) | 116.59 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
McKesson Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
McKesson Corp Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2027 | 2027-02-04 16:30 | In 146 days | ||
| Third quarter earnings results for 2027 | 2027-02-04 | In 145 days | ||
| Second quarter earnings conference call for 2027 | 2026-11-05 16:30 | In 55 days | ||
| Second quarter earnings results for 2027 | 2026-11-05 | In 54 days | ||
| First quarter earnings conference call for 2027 | 2026-08-05 16:30 | -- | ||
| First quarter earnings results for 2027 | 2026-08-05 | -- | ||
| General meeting for 2026 | 2026-07-22 08:30 | -- | ||
| Annual report for 2026 | 2026-05-08 | -- | ||
| Fourth quarter earnings conference call for 2026 | 2026-05-07 16:30 | -- | ||
| Fourth quarter earnings results for 2026 | 2026-05-07 | -- |
Show
Entries
McKesson Corp Frequently Asked Questions
What is McKesson Corp(WBO:MCK)'s stock price today?
The current price of WBO:MCK is €754.80. The 52 week high of WBO:MCK is €766.40 and 52 week low is €754.80.
When is next earnings date of McKesson Corp(WBO:MCK)?
The next earnings date of McKesson Corp(WBO:MCK) is 2026-11-05 Est..
Does McKesson Corp(WBO:MCK) pay dividends? If so, how much?
McKesson Corp(WBO:MCK) does not pay dividend.
Press Release
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers